Search

Search Constraints

You searched for: Subject Cachexia

Search Results

461. Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice. Issue 1 (2nd December 2021)

463. Muscle‐to‐fat ratio identifies functional impairments and cardiometabolic risk and predicts outcomes: biomarkers of sarcopenic obesity. Issue 1 (5th December 2021)

464. Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality. Issue 1 (30th November 2021)

465. Muscle‐specific functional deficits and lifelong fibrosis in response to paediatric radiotherapy and tumour elimination. Issue 1 (8th January 2022)

466. Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients. Issue 1 (22nd December 2021)

467. Chronic aryl hydrocarbon receptor activity phenocopies smoking‐induced skeletal muscle impairment. Issue 1 (1st November 2021)

468. CircRNAome profiling reveals circFgfr2 regulates myogenesis and muscle regeneration via a feedback loop. Issue 1 (22nd November 2021)

469. Histomorphological and inflammatory changes of white adipose tissue in gastrointestinal cancer patients with and without cachexia. Issue 1 (22nd December 2021)

470. MyD88 deficiency ameliorates weight loss caused by intestinal oxidative injury in an autophagy‐dependent mechanism. Issue 1 (22nd November 2021)